Young Blood Clinical Study at the Maharaj Institute in Florida

Thursday, February 28, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

BOYNTON BEACH, Fla., Feb. 28, 2019 /PRNewswire/ -- The South Florida Bone Marrow/Stem Cell Transplant Institute DBA

Maharaj Institute of Immune Regenerative Medicine in Boynton Beach, Florida, is conducting a "Phase 1/2 Clinical Study Evaluating the Safety and Efficacy of Fresh Frozen Plasma (GMFFP) from young healthy donors ages 18 to 35, who have received Granulocyte - Colony Stimulating Factor (G-CSF) to Ameliorate Frailty and Enhance the Immune Risk Profile in Older Individuals."

This Study is under an FDA (Food and Drug Administration) IND (Investigational New Drug Application) and is IRB (Institutional Review Board) approved as per the FDA guidelines. We are following all the FDA guidelines and have a Principal Investigator overseeing the study. The FDA has issued an IND number for the study and a copy of this FDA communication, acknowledging the IND is available on request to qualified consumers considering treatment. Study participants are not being charged for the treatments, the follow up or treatment side effects associated with this study.

Cision View original content:http://www.prnewswire.com/news-releases/young-blood-clinical-study-at-the-maharaj-institute-in-florida-300803654.html

SOURCE Maharaj Institute of Immune Regenerative Medicine



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store